- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 193 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 199 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- July 2025
- 350 Pages
Global
From €4365EUR$4,949USD£3,778GBP
From €6614EUR$7,500USD£5,726GBP
- Report
- December 2024
- 436 Pages
Global
From €3528EUR$4,000USD£3,054GBP
- Report
- January 2025
- 209 Pages
Global
From €4405EUR$4,995USD£3,814GBP
- Report
- July 2025
- 84 Pages
Europe
From €5287EUR$5,995USD£4,577GBP
- Report
- July 2025
- 73 Pages
North America
From €5287EUR$5,995USD£4,577GBP
- Report
- July 2025
- 80 Pages
Asia Pacific
From €5287EUR$5,995USD£4,577GBP
- Report
- August 2025
- 439 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- March 2025
- 176 Pages
Global
From €5247EUR$5,950USD£4,543GBP
- Report
- February 2025
- 135 Pages
Global
From €2645EUR$2,999USD£2,290GBP
- Report
- April 2025
- 400 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 194 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 189 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 196 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 180 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 190 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP

The Cardiac Marker Testing market is a subset of the Laboratory Testing market, which focuses on the diagnosis and monitoring of cardiac diseases. Cardiac markers are proteins or enzymes released into the bloodstream in response to cardiac injury or stress. These markers can be used to diagnose and monitor a variety of cardiac conditions, such as myocardial infarction, congestive heart failure, and arrhythmias. Cardiac marker testing is typically performed using immunoassay techniques, such as ELISA, CLIA, and chemiluminescence.
Cardiac marker testing is an important tool for the diagnosis and management of cardiac diseases, and is used in both clinical and research settings. It is also used to monitor the effectiveness of treatments and to assess the risk of future cardiac events.
Companies in the Cardiac Marker Testing market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more